Evdokiou A - Search Results

1

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.

Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Findlay DM, Zannettino AC, Evdokiou A. Zinonos I, et al. Among authors: evdokiou a. J Bone Miner Res. 2011 Mar;26(3):630-43. doi: 10.1002/jbmr.244. J Bone Miner Res. 2011. PMID: 20818644 Free PMC article.

2

Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest.

Evdokiou A, Raggatt LJ, Atkins GJ, Findlay DM. Evdokiou A, et al. Mol Endocrinol. 1999 Oct;13(10):1738-50. doi: 10.1210/mend.13.10.0359. Mol Endocrinol. 1999. PMID: 10517675

3

Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.

Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM. Atkins GJ, et al. Among authors: evdokiou a. J Bone Miner Res. 2000 Apr;15(4):640-9. doi: 10.1359/jbmr.2000.15.4.640. J Bone Miner Res. 2000. PMID: 10780856 Free article.

4

Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells.

Kitahama S, Gibson MA, Hatzinikolas G, Hay S, Kuliwaba JL, Evdokiou A, Atkins GJ, Findlay DM. Kitahama S, et al. Among authors: evdokiou a. Bone. 2000 Jul;27(1):61-7. doi: 10.1016/s8756-3282(00)00292-1. Bone. 2000. PMID: 10865210

5

Identification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene.

Evdokiou A, Raggatt LJ, Sakai T, Findlay DM. Evdokiou A, et al. J Mol Endocrinol. 2000 Oct;25(2):195-206. doi: 10.1677/jme.0.0250195. J Mol Endocrinol. 2000. PMID: 11013346

6

Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor.

Raggatt LJ, Evdokiou A, Findlay DM. Raggatt LJ, et al. Among authors: evdokiou a. J Endocrinol. 2000 Oct;167(1):93-105. doi: 10.1677/joe.0.1670093. J Endocrinol. 2000. PMID: 11018757

7

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM. Atkins GJ, et al. Among authors: evdokiou a. Bone. 2001 Apr;28(4):370-7. doi: 10.1016/s8756-3282(01)00404-5. Bone. 2001. PMID: 11336917

8

Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.

Evdokiou A, Atkins GJ, Bouralexis S, Hay S, Raggatt LJ, Cowled PA, Graves SE, Clayer M, Findlay DM. Evdokiou A, et al. Int J Oncol. 2001 Sep;19(3):625-32. doi: 10.3892/ijo.19.3.625. Int J Oncol. 2001. PMID: 11494046

9

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM. Evdokiou A, et al. Int J Cancer. 2002 Jun 1;99(4):491-504. doi: 10.1002/ijc.10376. Int J Cancer. 2002. PMID: 11992538

10

Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL.

Clayer M, Bouralexis S, Evdokiou A, Hay S, Atkins GJ, Findlay DM. Clayer M, et al. Among authors: evdokiou a. J Orthop Surg (Hong Kong). 2001 Dec;9(2):19-22. doi: 10.1177/230949900100900205. J Orthop Surg (Hong Kong). 2001. PMID: 12118126 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters